Try a single issue or save on a subscription Issues delivered straight to your door or device ...
A fan of Lopatin’s early ambient releases, Josh Safdie contacted him while working out the sonic and emotional landscape of ...
Lace up and uncover Indiana’s hidden trails, where forests, ravines, and ridges offer peace, adventure, and breathtaking ...
Cities 97.1 entertained listeners in an unexpected fashion on Tuesday night. In what appeared to be a technical error around 7:30 p.m., the station began looping a ...
The Thanksgiving holiday has come and gone, but the annoyances of San Antonio construction among drivers in the Alamo City remain, as the Texas Department of Transportation has unveiled a weeklong ...
Rush Hour 4 is reportedly in the works at Paramount, which merged with Skydance Media earlier this year. According to multiple outlets, the green light for the production was all thanks to Donald ...
CHICAGO (WGN) — A 14-year-old boy shot and killed Friday night in the Loop, just hours after the city’s annual Christmas tree lighting downtown, is being remembered as a funny, basketball-loving teen ...
Marissa Sulek joined CBS News Chicago in January 2025. Before Chicago, Marissa was a general assignment reporter in Nashville at WSMV, where she was nominated for Mid-South Emmy Awards for her ...
Hosted on MSN
1 dead, 8 wounded after 2 shootings in the Loop, hours after Chicago's Christmas tree lighting
One person died and eight people were wounded in a pair of shootings late Friday night in the Loop, just hours after Chicago lit the city's official Christmas tree. Body Language Experts Say Marjorie ...
Hosted on MSN
At least 6 people wounded in 2 shootings in the Loop hours after Chicago's Christmas tree lighting
At least six people were wounded in a pair of shootings late Friday night in the Loop, just hours after Chicago lit the city's official Christmas tree just blocks away in Millennium Park. Marjorie ...
Selumetinib received FDA approval for adults with NF1 and symptomatic, inoperable plexiform neurofibromas, based on the phase 3 KOMET trial results. The KOMET trial showed a 20% objective response ...
The FDA has approved selumetinib (Koselugo, AstraZeneca) for adults with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN). With the new regulatory decision, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback